Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01571531 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

European Multicentre Study of Human Spinal Cord Injury

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2026 → Dec 2026
See other at-risk trials from University of Zurich

Record History

  1. Minor Primary and study completion pushed from Aug 2026 to Dec 2026 Eligibility criteria expanded, about 8 words · Publications: details revised at 6 of 6 entries Show 2 more changesShow less
    • Eligibility criteria expanded, about 8 words
    • Publications: details revised at 6 of 6 entries
  2. Minor 2 versions Re-verified since Nov 14, 2024, no change to tracked fieldsv18-v19
  3. Minor Enrollment target: 5500 to 8000v17
  4. Minor 4 versions Re-verified since Aug 8, 2019, no change to tracked fieldsv13-v16
  5. Notable Primary endpoints revised (4)v12 See this version in full on ClinicalTrials.gov ↗
Show 10 earlier versionsHide 10 earlier versions
  1. Notable Primary endpoints: 1 to 4v11 See this version in full on ClinicalTrials.gov ↗
  2. Minor 2 versions Re-verified since Nov 1, 2017, no change to tracked fieldsv9-v10
  3. Minor Completion date: Aug 2026v8
  4. Notable Enrollment target: 2300 to 5500 Primary completion date: Aug 2016 to Aug 2026 · Primary endpoint revisedv7 Show 2 more changesShow less
    • Primary completion date: Aug 2016 to Aug 2026
    • Primary endpoint revised

    See this version in full on ClinicalTrials.gov ↗

  5. Minor Re-verified, no change to tracked fieldsv6
  6. Notable Primary completion date: Jan 2016 to Aug 2016v5
  7. Minor Re-verified, no change to tracked fieldsv4
  8. Minor Primary completion date: Jan 2016v3
  9. Minor Study site revisedv2 See this version in full on ClinicalTrials.gov ↗
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Today there is accumulating evidence from animal experiments that regeneration can be induced after a spinal cord injury (SCI). Consequently in the near future, new therapeutic approaches to induce some regeneration will be included in the treatment of patients with SCI. The aim of this proposal is to provide the required clinical basis for the implementation of novel interventional therapies. The establishment of combined clinical, functional and neurophysiological measures for a qualitative and quantitative assessment of spinal cord function in patients with SCI at different stages during rehabilitation represents a basic requirement to monitor any significant effect of a new treatment. Therefore, several European Paraplegic Centres involved in the rehabilitation of acute traumatic SCI patients build up a close collaboration for standardised assessment. The aim is to get knowledge about the natural recovery after spinal cord lesion in a larger population of patients in the sense of a historical control group and to bring new standardised assessment tools to the clinical setting.
Trial Details
NCT Number NCT01571531
Lead Sponsor University of Zurich
Conditions Spinal Cord Injury
Enrollment 8,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov